10.01.25 -- Alzheimer's Trial Targeting Amyloid Beta Oligomers Sees Cost Savings, Patient Satisfaction With New Screening

Examine the potential ramifications of proposed tariffs on the pharmaceutical and biotechnology sectors, highlighting critical concerns regarding national security and supply chain stability.

From sleepiness scales to computerized cognitive testing, narcolepsy research now relies on tools like the CDR System to reveal the full impact of treatments on patients’ daily lives.

With tailored guidance, sponsors can align their modern model-based and model-assisted design choices to program goals, accelerating progress while safeguarding patients.

In this presentation, industry experts will share real-world lessons learned from managing global early-phase oncology trials.

What is a Simon 2-stage design, and how was it used to enable each tumor-specific cohort in a Phase 2, multi-cohort oncology trial to be independently assessed for objective response rates?

Learn how community- and patient-centric site networks that have DCT capabilities are able to work with a broad-range of site types.

Are you seeking a non-traditional option to complete the eye exams necessary for your ocular clinical trials? A mobile clinic may be the solution you're looking for.